Water-dispersible tablets

Details Water-dispersible tablets Water-dispersible tablets

1994-10-03

1997-08-26

Bawa, Raj

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

424465, 424468, 424469, 424484, 514770, 514934, 514965, A61K 920

Patent

active

056608608

ABSTRACT:
A water-dispersible tablet comprises acyclovir and a dispersing agent. The dispersing agent is a swellable clay such as a smectite, e.g. Veegum F or bentonite, and is generally present within the granules of the tablet to provide a tablet which is capable of dispersing in water within 3 minutes to provide a dispersion which will pass through a 710 .mu.m sieve. The tablet can be optionally film-coated in which case the dispersion time is less than 5 minutes.

REFERENCES:
patent: 3427379 (1969-02-01), Barry et al.
patent: 3432593 (1969-03-01), Shepard
patent: 3567819 (1971-03-01), Leonia et al.
patent: 4072535 (1978-02-01), Short et al.
patent: 4086335 (1978-04-01), Bruscata et al.
patent: 4159345 (1979-06-01), Takeo et al.
patent: 4209513 (1980-06-01), Toroda
patent: 4251513 (1981-02-01), Moore et al.
patent: 4304773 (1981-12-01), Wong et al.
patent: 4305502 (1981-12-01), Gregory et al.
patent: 4322449 (1982-03-01), Vosds et al.
patent: 4369308 (1983-01-01), Trubiano
patent: 4371516 (1983-02-01), Gregory et al.
patent: 4414198 (1983-11-01), Michaelson
patent: 4517179 (1985-05-01), Raghunathan
patent: 4600579 (1986-07-01), Salpekar et al.
patent: 4602017 (1986-07-01), Sawyer et al.
patent: 4631305 (1986-12-01), Guyer et al.
patent: 4661521 (1987-04-01), Salpekar et al.
patent: 4711777 (1987-12-01), Tan et al.
patent: 4757090 (1988-07-01), Salpekar et al.
patent: 4774083 (1988-09-01), Tan et al.
patent: 4781925 (1988-11-01), Michelucci et al.
patent: 4832956 (1989-05-01), Gergely et al.
patent: 4837031 (1989-06-01), Denton et al.
patent: 4847249 (1989-07-01), Sawyer et al.
patent: 4904477 (1990-02-01), Ho et al.
patent: 4910023 (1990-03-01), Botzolakis et al.
patent: 4925676 (1990-05-01), Selassie et al.
patent: 4927639 (1990-05-01), Selassi et al.
patent: 4950484 (1990-08-01), Olthoff et al.
patent: 4965072 (1990-10-01), Alexander et al.
patent: 4968517 (1990-11-01), Gergely et al.
patent: 4970078 (1990-11-01), Holinej
patent: 4999200 (1991-03-01), Casilian
patent: 5006345 (1991-04-01), Lang
patent: 5037658 (1991-08-01), Urban et al.
patent: 5047247 (1991-09-01), Milovac et al.
patent: 5049586 (1991-09-01), Ortega et al.
patent: 5064656 (1991-11-01), Gergely et al.
patent: 5069910 (1991-12-01), Kovacic et al.
patent: 5073377 (1991-12-01), Alexander et al.
patent: 5085869 (1992-02-01), Olthoff et al.
patent: 5087454 (1992-02-01), Duerholz et al.
patent: 5136080 (1992-08-01), Miller et al.
Rudnic et al, Drug Development and Industrial Pharmacy 7(3), pp. 347-358 (1981).
Patel, N.K., Kennon L and Levinson S.R., Pharmaceutical Suspensions, Chapter 16 from the Theory and Practice of Industrial Pharmacy (ed Lachman, Lieberman and Kanig), 1986.
Lowenthal J. Pharm Sci, vol. 61: No. 11, pp. 1695-1711 (1972).
Holstius et al; J. Amer. Pharm. Sci 41,505 (1952).
Patel et al, Indian J. Pharm. 26,313 (1964).
Patel et al. Indian J. Pharm. 28,244 (1966).
Smeczi et al. Acta Pharm. Hungary, 40, 124 (1970).
Bilups et al, Amer J. Pharm. 136,25 (1964).
Patel et al. Indian J. Pharm., 25,220 (1963).
Birmancevic et al. Arh. Farm. 31 (1-2),45-54 (1981).
Birmancevic et al. Acta, Pharmaceutica Yugoslavia 237-240 (1974).
Birmancevic et al. (Arch. Farm. 28, 21-28 (1978).
Borzonuv et al. Chem Abstr., 69 1097q (1968).
Borzonuv et al. Chem Abst., 71 3385y (1969).
Selmeczi et al. Chem Abst 70, 14395q (1969).
Saufiulin et al. Chem Abst 58, 13727a (1963).
Kuever et al. J. American Pharm. Ass. Sci, 17, 365 (1928).
Shotton et al J. Pharm Pharmac., 24, 798-803 (1972).
Shotton et al J. Pharm. Sci., 65 1170-1174 (1976).
Pennwalt Corp; Raghunathan, Y, pp. 1-33; 27678; Cellulose and Starch (1984).
Faracia Polska; No. 7, pp. 505-509 (1966).
Britain Pharmacopeia vol. 11, pp. 891-895 (1988).
R. F. Shangraw; University of Maryland; "Specialty Tablets and Capsules" pp. 427-440-(1990).
Veegum - The Supernatural Ingredient: R. T. Vanderbilt & Co., Booklet (1987).
Pharmasorb: Lawrence Industries, pp. 1-10 (1986).
Wal et al "Applications of the Montmorillonites in Tablet Making" J. Pharm. Sci., 55: 1244-1248 (1966).
Wai & Banker "Some Physicochemical Properties of the Montmorillonites" J. Pharm. Sci., 55, 1215-1220 (1966).
Granberg et al "The use of Dried Bentonite as a Disintegrating Agent in Compressed Tablets of Thyroid" J. Am. Pharm. Asoc. Sci., 43: 648-7651 (1949).
Gross et al "A Comparative Study of Tablet disintegrating Agents": J. Am. Pharm. Assoc. Sci., 41: 157-161 (1952).
Firouzabadian et al "Some recently Developed Chemicals as Disintegrating Agents for Compressed Tablets": J. Am. Pharm. Assoc. Sci., 43 248-250 (1954).
Ward et al "Evaluation of Tablet Disintegrants" Drug Cosmetic Ind. 91: 35-36, 92, 110-111 (1962).
Nair et al "Studies on Disintegration of Compressed Tablets I. Effect on Disintegration of the Procedure Used in Incorporating the Disintegrating Agent": J. Am Pharm. Assoc. Sci., 46: 131-134 (1957).
Patel et al "Veegum as Binding Agent for Compressed Tablets" Indian J. Pharm., 19: 4-10 (1957).
Feinstein et al "Comparative Study of Selected Disintegrating Agents": J. Pharm. Sci. 55: 332-334 (1966).
Varley, A, "The generic Inequivalence of Drugs" JAMA, 206: 1745-1748 (1968).
Delonca et al "Study of the Activity of Some Disintegrants as a Function of Procedure and of the Solubility of the Active Principles" J. Pharm. Belg. 26(4): 447-458 (1971).
Wagner et al "In vivo and In vitro availability of Commercial Warfarin Tablets" J. Pharm. Sci. 60:666-677 (1971).
McGinty et al "Optimization of Slow-Release Tablet Formulations Containing Montmorillonite I. Properties of Tablets" Drug Development and Industrial Pharmacy 6: 399-410 (1980).
Bargava et al "An Evaluation of Smecta as a Tablet Disintegrant and Dissolution Aid" Drug Development and Industrial Pharmacy 17: 2093-2102 (1991).
Barr, M. "In Pharmaceutical Systems . . . Clays as Dispersion Stabilizers" J. Amer. Pharm. Assoc. Sci. Ed. 46: 486-493 (1957).
U.S. Pharmacopoeia, pp. 579, 1573, 1574, 1534 and 1535 (1985).
British Pharmacopoeia, pp. 27, 28, 51, 52, 62, 323-325 (1985).
Martindale, The Extra Pharmacopoeia, 29th Edition, 1077, 1092 and 1433 (1989).
Armstrong, N. "Tableting" from Pharmaceutics: The Science of Dosage Form Design (Ed. Aulton): 647-668 (1988).
Rubinstein, M. "Tablets" from Pharmaceutics The Science of Dosage Form Design, (Ed. Aulton): 304-321 (1988).
Rudnic et al "Oral Solid Dosage Forms" from Remington's Pharmaceutical Sciences (Ed. Gennaro) pp. 1633-1665 (1990).
Disento, A. "Bioavailability and Bioequivalency Testing" from Remington's Pharmaceutical Sciences (ed. Gennaro), pp. 1451-1458 (1990).
Marshall et al "Tablet Dosage Forms" from Modern Pharmaceutics (eds. Banker G & Rhodes C) pp. 355-425 (1990).
Shangraw R. "Specialty Tablet and Capsules" from Modern Pharmaceutics (eds. Banker, G & Rhodes, C) pp. 427-440 (1990).

Affiliated with

Also associated with

Rating

Water-dispersible tablets does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Water-dispersible tablets, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Water-dispersible tablets will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1986500